Earnings Call · Q2 FY2023·2023-08-02

Q2 23EPS +5.71%·Rev n/aQ1 23EPS -8.11%·Rev n/aQ4 22EPS +20.00%·Rev n/aQ3 22EPS +15.79%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad Robins — Chief Executive Officer

Tycho Peterson — Chief Financial Officer

−3.5%1d on move date−2.1% vs SPY3d−17.2%5d−19.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access